Logo image of TMDX

TRANSMEDICS GROUP INC (TMDX) Stock Overview

NASDAQ:TMDX - US89377M1099 - Common Stock

116.48 USD
-3.37 (-2.81%)
Last: 8/25/2025, 2:06:31 PM

TMDX Key Statistics, Chart & Performance

Key Statistics
52 Week High177
52 Week Low55
Market Cap3.97B
Shares34.09M
Float33.06M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)1.93
PE60.35
Fwd PE41.76
Earnings (Next)10-27 2025-10-27/amc
IPO05-02 2019-05-02
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


TMDX short term performance overview.The bars show the price performance of TMDX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60

TMDX long term performance overview.The bars show the price performance of TMDX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100

The current stock price of TMDX is 116.48 USD. In the past month the price increased by 10.85%. In the past year, price decreased by -31.77%.

TRANSMEDICS GROUP INC / TMDX Daily stock chart

TMDX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.08 230.96B
ISRG INTUITIVE SURGICAL INC 58.62 169.16B
BSX BOSTON SCIENTIFIC CORP 37.38 156.75B
SYK STRYKER CORP 30.4 149.33B
MDT MEDTRONIC PLC 16.71 118.36B
BDX BECTON DICKINSON AND CO 13.66 55.88B
IDXX IDEXX LABORATORIES INC 53.51 51.42B
EW EDWARDS LIFESCIENCES CORP 31.56 47.62B
RMD RESMED INC 30.32 42.39B
GEHC GE HEALTHCARE TECHNOLOGY 16.02 34.08B
DXCM DEXCOM INC 45.38 30.26B
PHG KONINKLIJKE PHILIPS NVR- NY 16.62 26.73B

About TMDX

Company Profile

TMDX logo image TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 728 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Company Info

TRANSMEDICS GROUP INC

200 Minuteman Road

Andover MASSACHUSETTS 01810 US

CEO: Waleed H. Hassanein

Employees: 728

TMDX Company Website

TMDX Investor Relations

Phone: 19785520900

TRANSMEDICS GROUP INC / TMDX FAQ

What is the stock price of TRANSMEDICS GROUP INC today?

The current stock price of TMDX is 116.48 USD. The price decreased by -2.81% in the last trading session.


What is the ticker symbol for TRANSMEDICS GROUP INC stock?

The exchange symbol of TRANSMEDICS GROUP INC is TMDX and it is listed on the Nasdaq exchange.


On which exchange is TMDX stock listed?

TMDX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for TRANSMEDICS GROUP INC stock?

16 analysts have analysed TMDX and the average price target is 154.02 USD. This implies a price increase of 32.23% is expected in the next year compared to the current price of 116.48. Check the TRANSMEDICS GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TRANSMEDICS GROUP INC worth?

TRANSMEDICS GROUP INC (TMDX) has a market capitalization of 3.97B USD. This makes TMDX a Mid Cap stock.


How many employees does TRANSMEDICS GROUP INC have?

TRANSMEDICS GROUP INC (TMDX) currently has 728 employees.


What are the support and resistance levels for TRANSMEDICS GROUP INC (TMDX) stock?

TRANSMEDICS GROUP INC (TMDX) has a support level at 117.3 and a resistance level at 125.66. Check the full technical report for a detailed analysis of TMDX support and resistance levels.


Is TRANSMEDICS GROUP INC (TMDX) expected to grow?

The Revenue of TRANSMEDICS GROUP INC (TMDX) is expected to grow by 39.73% in the next year. Check the estimates tab for more information on the TMDX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy TRANSMEDICS GROUP INC (TMDX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TRANSMEDICS GROUP INC (TMDX) stock pay dividends?

TMDX does not pay a dividend.


When does TRANSMEDICS GROUP INC (TMDX) report earnings?

TRANSMEDICS GROUP INC (TMDX) will report earnings on 2025-10-27, after the market close.


What is the Price/Earnings (PE) ratio of TRANSMEDICS GROUP INC (TMDX)?

The PE ratio for TRANSMEDICS GROUP INC (TMDX) is 60.35. This is based on the reported non-GAAP earnings per share of 1.93 and the current share price of 116.48 USD. Check the full fundamental report for a full analysis of the valuation metrics for TMDX.


What is the Short Interest ratio of TRANSMEDICS GROUP INC (TMDX) stock?

The outstanding short interest for TRANSMEDICS GROUP INC (TMDX) is 23.38% of its float. Check the ownership tab for more information on the TMDX short interest.


TMDX Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to TMDX. When comparing the yearly performance of all stocks, TMDX is a bad performer in the overall market: 89.01% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

TMDX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to TMDX. TMDX has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TMDX Financial Highlights

Over the last trailing twelve months TMDX reported a non-GAAP Earnings per Share(EPS) of 1.93. The EPS increased by 4725% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.49%
ROA 8.05%
ROE 22.53%
Debt/Equity 1.61
Chartmill High Growth Momentum
EPS Q2Q%162.86%
Sales Q2Q%37.68%
EPS 1Y (TTM)4725%
Revenue 1Y (TTM)48.09%

TMDX Forecast & Estimates

16 analysts have analysed TMDX and the average price target is 154.02 USD. This implies a price increase of 32.23% is expected in the next year compared to the current price of 116.48.

For the next year, analysts expect an EPS growth of 138.21% and a revenue growth 39.73% for TMDX


Analysts
Analysts81.25
Price Target154.02 (32.23%)
EPS Next Y138.21%
Revenue Next Year39.73%

TMDX Ownership

Ownership
Inst Owners121.6%
Ins Owners2.98%
Short Float %23.38%
Short Ratio7.2